Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO

A pharmaceuticals sector exchange traded fund perked up Friday after Endo International (NasdaqGS: ENDP) Chief Executive Rajiv De Silva stepped aside to be replaced by generics division head Paul Campanelli. The SPDR Pharmaceuticals ETF (NYSEArca: XPH) rose 0.8% Friday. Meanwhile, ENDP shares...